HCM
AXSM icon

Howland Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Howland Capital Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$543K Hold
2,220
– – 0.02% 203
2026
Q1 		$375K Hold
2,220
– – 0.01% 225
2025
Q4 		$405K Buy
+2,220
New +$310K 0.02% 210

Other funds holding AXSM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
CA
Cannon Advisors Charlotte, North Carolina $164M AUM 30.34% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

Howland Capital Management's AXSM Position: Q2 2026 in Review

Howland Capital Management held its Axsome Therapeutics (AXSM) position steady in Q2 2026 at 2,220 shares worth $543K. The position accounts for 0.02% of the portfolio, ranked #203.

Howland Capital Management first reported a position in AXSM in Q4 2025 and has held it in 3 quarters since. 38 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Howland Capital Management held 2,220 shares of Axsome Therapeutics worth $543K as of Q2 2026.
  • Howland Capital Management left its Axsome Therapeutics share count unchanged in Q2 2026.
  • Axsome Therapeutics made up 0.02% of Howland Capital Management's portfolio in Q2 2026, its #203 holding.
  • Howland Capital Management first reported a position in Axsome Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 38 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Howland Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.